April 2024
-
04.29.2024
Prescription Medicines Medicines FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer
-
04.26.2024
Prescription Medicines Medicines U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B
-
04.22.2024
Prescription Medicines Medicines European Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options
March 2024
-
03.12.2024
February 2024
-
02.19.2024
Prescription Medicines Medicines European Commission Approves Pfizer’s VELSIPITY® for Patients with Moderately to Severely Active Ulcerative Colitis
January 2024
-
01.26.2024
-
01.09.2024
-
01.08.2024
December 2023
-
12.15.2023
October 2023
-
10.13.2023
Prescription Medicines Medicines U.S. FDA Approves Pfizer’s VELSIPITY™ for Adults with Moderately to Severely Active Ulcerative Colitis (UC)
-
10.12.2023
Prescription Medicines Medicines U.S. FDA Approves Pfizer’s BRAFTOVI® + MEKTOVI® for BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
June 2023
-
06.23.2023
Prescription Medicines Medicines FDA Approves Pfizer’s LITFULO™ (Ritlecitinib) for Adults and Adolescents With Severe Alopecia Areata